Skip to content
Screener

uniQure QURE Pre-Tax Income

Pre-Tax Income at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$1.75M-101%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$2.46M-100%
Opus Genetics logo
Opus GeneticsIRD
-$65.54M-700%
Arvinas logo
ArvinasARVN
-$57.5M-169%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$91M+20.2%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Interest expense(14,366)(15,591)(28,397)(30,700)
Foreign currency (losses) / gains, net(1,730)18,638(4,024)25,810
Other non-operating (losses), net(15,970)(12,201)
Loss before income tax expense$(79,218)$(37,294)$(132,265)$(80,435)
Income tax expense(1,841)(425)(2,329)(921)
Net loss$(81,059)$(37,719)$(134,594)$(81,356)
Other comprehensive loss:
Foreign currency translation gains / (losses), net1,634(5,098)(29)(6,103)

Item 1.Financial Statements

FAQ

What is uniQure's pre-tax income?
uniQure (QURE) reported pre-tax income of -$79.22M in Q2 2026.
How has uniQure's pre-tax income changed year-over-year?
uniQure's pre-tax income decreased by 112.4% year-over-year, from -$37.29M to -$79.22M.
What is the long-term trend for uniQure's pre-tax income?
Over 4 years (2021 to 2025), uniQure's pre-tax income has grown at a -12.7% compound annual growth rate (CAGR), from $332.81M to -$193.34M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about uniQure's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude